Results 1 to 10 of about 4,151 (165)
Purpose: Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been associated with a lower progression rate of low risk prostate cancer.
Caroline M Moore +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
Journal of Urology, 2009Satyan K Shāh +2 more
exaly

